Limitations, agreements, and source contact

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV · Source last updated 2026-05-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restriction Type

LTE60

restrictive Agreement

true

point Of Contact

email

hcheng@montefiore.org

organization

Albert Einstein College of Medicine, Montefiore Einstein Comprehensive Cancer Center

phone

718-405-8404

title

Haiying Cheng, MD - Associate Professor, Department of Oncology

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice